Results 221 to 230 of about 929,362 (315)

Pyoderma gangrenosum in a patient with multiple sclerosis under natalizumab treatment: a case report. [PDF]

BMC Neurol
Kohandel K, Ala S, Tamizifar B, Karaminia M, Sahraian M.   +4 more
europepmc   +1 more source

Rituximab in combination with mycophenolate mofetil in a patient with rapidly progressive systemic sclerosis and cyclophosphamide cardiotoxicity

Aleksandra Zoń‐Giebel, Daria Wolak
openalex   +1 more source

Use of rituximab in connective tissue disease-associated interstitial lung disease: a narrative review. [PDF]

Front Med (Lausanne)
Xu C, Xu Z, Ren J.
europepmc   +1 more source

A unifying model for multiple sclerosis. [PDF]

Clin Exp Med
Park DJ.
europepmc   +1 more source

Serum CXCL-13 levels in patients with progressive systemic sclerosis are associated with the severity of interstitial lung disease

Derya Yıldırım, Abdülsamet Erden, Ibrahim Vasi, Aslıhan Avanoğlu Güler, Rahime Duran, Rıza Can Kardaş, Burcugül Kaya, Gizem Tuğçe, Hamit Küçük, Nilgün Yılmaz Demirci, Berna Göker, Mehmet Akif Öztürk   +11 more
openalex   +1 more source

Myelopoiesis is temporally dynamic and is regulated by lifestyle to modify multiple sclerosis. [PDF]

Nat Commun
Yates AG, Khamhoung A, Gaebel L, Jacob W, Radford-Smith DE, Kiss MG, Huynh P, Gerhardt T, Heiser M, Cohen O, Swirski FK, Anthony DC, Sumowski J, Katz Sand I, McAlpine CS.   +14 more
europepmc   +1 more source

Clinical course and potential associated factors of progressive calcinosis cutis in early systemic sclerosis: a cohort study

Vassana Kanjanajarurat, Prathana Chowchuen, Chingching Foocharoen, Punthip Thammaroj   +3 more
openalex   +1 more source

Management of adrenocortical adenoma in systemic sclerosis: A case report. [PDF]

J Int Med Res
Luo Z, Shi Y, Yang J, Duan Y, Wang Q, Li C, Yang S, Peng B, Zhang K, Yang L, Zhao B, Bi C.   +11 more
europepmc   +1 more source

Systemic sclerosis: key clinical features of a rare and progressive disease

Anshu Tikariha
openalex   +1 more source